From: Comprehensive evaluation of otorhinolaryngological symptoms in COVID-19 patients
Symptom | Order of symptom in disease manifestation | Count | % |
---|---|---|---|
Headache | I | 92 | 13.4% |
II | 74 | 10.8% | |
III | 42 | 6.1% | |
IV | 38 | 5.5% | |
Nasal obstruction | I | 18 | 2.6% |
II | 34 | 5.0% | |
III | 12 | 1.7% | |
IV | 42 | 6.1% | |
Nasal discharge | I | 24 | 3.5% |
II | 62 | 9.0% | |
III | 18 | 2.6% | |
Postnasal discharge | III | 40 | 5.8% |
IV | 10 | 1.5% | |
V | 16 | 2.3% | |
Sneezing | III | 10 | 1.5% |
IV | 8 | 1.2% | |
Anosmia | I | 108 | 15.7% |
II | 74 | 10.8% | |
III | 36 | 5.2% | |
IV | 28 | 4.1% | |
V | 38 | 5.5% | |
Sore throat | I | 42 | 6.1% |
II | 126 | 18.4% | |
III | 38 | 5.5% | |
V | 26 | 3.8% | |
VII | 56 | 8.2% | |
Dysphagia | I | 4 | 0.6% |
II | 38 | 5.5% | |
III | 12 | 1.7% | |
V | 16 | 2.3% | |
Cough | I | 54 | 7.9% |
II | 76 | 11.1% | |
III | 98 | 14.3% | |
IV | 80 | 11.7% | |
V | 28 | 4.1% | |
Dry mouth | I | 2 | 0.3% |
III | 28 | 4.1% | |
V | 8 | 1.2% | |
Earache | I | 14 | 2.0% |
II | 20 | 2.9% | |
Tinnitus | III | 10 | 1.5% |
IV | 2 | 0.3% | |
Vertigo | I | 8 | 1.2% |
V | 14 | 2.0% | |
Expectoration | II | 20 | 2.9% |
III | 24 | 3.5% | |
IV | 20 | 2.9% |